Michael Maynard

Michael Maynard is a strategic project planning and controls leader with over a decade of experience delivering complex, schedule-driven capital programs across the life sciences sector. As Vice President at Stelic, Michael specializes in building execution-ready schedules that support commissioning, qualification, validation (CQV), shutdowns, and operational readiness for highly regulated environments.
Michael’s expertise spans the full project lifecycle, from early design through construction, commissioning, tech transfer, and production readiness. He is highly skilled in developing phase-driven master schedules that integrate field execution realities with advanced planning tools such as Primavera P6, Microsoft Project, and Touchplan. This approach provides leadership teams with clear visibility into sequencing, resource constraints, and critical path risks, enabling confident, data-driven decision-making.
Throughout his career, Michael has led major scheduling efforts for global pharmaceutical and biotech clients including AstraZeneca, Novo Nordisk, Takeda, Pfizer, and Thermo Fisher Scientific. His work includes CQV planning for GMP and non-GMP systems, cleanroom retrofits, rapid-turnaround shutdowns, and large-scale tech transfer initiatives. By leveraging predictive analytics, issue tracking, and schedule-driven visual reporting, Michael proactively identifies conflicts, mitigates execution risk, and maintains momentum under compressed timelines.
A U.S. Navy veteran, Michael brings operational discipline, structured problem-solving, and team-oriented leadership to every engagement. At Stelic, he plays a key role in advancing the firm’s project controls and scheduling practice by strengthening schedule enforcement, milestone management, and owner-side planning support. His leadership reinforces Stelic’s commitment to clarity, reliability, and hands-on value delivery across complex capital programs.